Use of metformin following a population-level intervention to encourage people with pre-diabetes to enroll in the National Diabetes Prevention Program
Guardado en:
Autores principales: | William H Herman, Laura N McEwen, Thomas E Hurst, Kevin L Joiner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b4dd59018e6344f6961c775f2cb3179a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
por: Giesje Nefs, et al.
Publicado: (2021) -
Evaluation and management of COVID-19-related severity in people with type 2 diabetes
por: Girish N Nadkarni, et al.
Publicado: (2021) -
Shape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin
por: C Wright, et al.
Publicado: (2021) -
Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK
por: Marcus Lind, et al.
Publicado: (2021) -
Lower extremity MRI following 10-week supervised exercise intervention in patients with diabetic peripheral neuropathy
por: Nathan Davis, et al.
Publicado: (2021)